(Q38963879)

8 September 2017

title

Identification of mutant alleles of JAK3 in pediatric patients with acute lymphoblastic leukemia (English)

1 reference

8 September 2017

Changhong Yin

1

1 reference

8 September 2017

Claudio Sandoval

series ordinal

2

1 reference

8 September 2017

Gyeong-Hun Baeg

series ordinal

3

1 reference

8 September 2017

publication date

21 January 2015

1 reference

8 September 2017

1 reference

8 September 2017

volume

56

1 reference

8 September 2017

issue

5

1 reference

8 September 2017

page(s)

1502-1506

1 reference

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Biology, risk stratification, and therapy of pediatric acute leukemias: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Cytokine signaling in 2002: new surprises in the Jak/Stat pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Janus kinases in immune cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

New insights into the regulation of T cells by gamma(c) family cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Activating alleles of JAK3 in acute megakaryoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Identification of a constitutively active mutant of JAK3 by retroviral expression screening

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Activating mutations in human acute megakaryoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

JAK mutations in high-risk childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Autophosphorylation of JAK2 on tyrosines 221 and 570 regulates its activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Significance of deeper molecular responses in patients with chronic myeloid leukemia in early chronic phase treated with tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2014.957204

10.3109/10428194.2014.957204

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference